Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma

NCT01476787 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1030

Enrollment

INDUSTRY

Sponsor class

Conditions

Follicular Lymphoma

Interventions

DRUG: Rituximab
DRUG: Lenalidomide
DRUG: Rituximab-CHOP
DRUG: Rituximab-CVP
DRUG: Rituximab-Bendamustine

Sponsor

Celgene

Collaborators

[object Object]